Write For Us

Emergent says it has disposed of spoilt Covid-19 vaccine batch

E-Commerce Solutions SEO Solutions Marketing Solutions
36 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
Johnson & Johnson's manufacturing partner Emergent BioSolutions said on Thursday that it had disposed of a single batch of COVID-19 drug substance that did not meet specifications, a day after J&J said it had found a problem with a batch being produced at Emergent's site in Baltimore, Maryland. Colette Luke has more.

Johnson & Johnson's manufacturing partner Emergent BioSolutions said on Thursday that it had disposed of the single batch of COVID-19 drug substance that did not meet specifications.

This comes after J&J said on Wednesday that it had found a problem with a batch of the drug substance for its COVID-19 vaccine being produced at Emergent's site in Baltimore, Maryland, adding that the batch did not advance to the final fill-and-finish stage.
Category
TV Saluran - TV Channel
Sign in or sign up to post comments.
Be the first to comment